S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat.
Both an excess and an imbalance of amino acids have been associated with total parenteral nutrition-induced cholestasis. The present study was undertaken to further our understanding of this condition in light of observations that methyl donor amino acids may be protective. Rats were maintained on Travasol (3.4 g amino acids/24 h) and dextrose (10.2 g/24 h) with and without the "active methyl" S-adenosylmethionine at a dose of 75 mg/kg/24 h for 5 days, and compared to control rats on dextrose alone (10.2 g/24 h) with free access to rat chow. Bile flow (microliters/min) was lower (p < 0.025) in the Travasol (8.65 +/- 0.78) than in the control group (12.30 +/- 0.52) and was restored in the Travasol+S-adenosylmethionine animals (11.42 +/- 10). Furthermore, the bile acid secretory rate (mumol/h) was higher (p < 0.05) with S-adenosylmethionine (23.34 +/- 3.71) than without S-adenosylmethionine (14.16 +/- 2.19). As expected, the molar ratio of biliary cholesterol was lower (p < 0.005) in both total parenteral nutrition groups. However, in the total parenteral nutrition group without S-adenosylmethionine, there was also a decrease in the molar ratio of phospholipids which correlated well with the bile acid secretory rate. Analysis of liver plasma membranes showed that a lower activity of Na+K(+)-ATPase (mumol Pi/mg protein/h) (p < 0.005) in the Travasol animals (6.26 +/- 0.53) was restored to control values (15.20 +/- 1.43) by the addition of S-adenosylmethionine (17.07 +/- 2.87). In the three groups, a close correlation was observed between Na+K(+)-ATPase activity and bile flow.(ABSTRACT TRUNCATED AT 250 WORDS)
Belli
D C
DC
Paediatric Gastroenterology Unit, Clinique Universitaire de Pédiatrie, Faculté de Médecine, Genève, Switzerland.
Fournier
L A
LA
Lepage
G
G
Yousef
I
I
Roy
C C
CC
D000596:Amino Acids; D000818:Animals; D001646:Bile / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D002779:Cholestasis / Q000209:etiology* / Q000517:prevention & control*; D002784:Cholesterol / Q000378:metabolism; D004573:Electrolytes; D002149:Energy Intake; D005947:Glucose; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008563:Membrane Lipids / Q000378:metabolism; D057947:Parenteral Nutrition Solutions; D010289:Parenteral Nutrition, Total / Q000009:adverse effects*; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012044:Regression Analysis; D012436:S-Adenosylmethionine / Q000494:pharmacology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D012996:Solutions
D000596:Amino Acids; D004573:Electrolytes; D008563:Membrane Lipids; D057947:Parenteral Nutrition Solutions; D010743:Phospholipids; D012996:Solutions; C545824:amino-acid, glucose, and electrolyte solution; D012436:S-Adenosylmethionine; D002784:Cholesterol; D000254:Sodium-Potassium-Exchanging ATPase; D005947:Glucose